Alere (ALRPRB.PFD) Net Margin % : -16.69% (As of Jun. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Alere Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Alere's Net Income for the three months ended in Jun. 2017 was $-93.07 Mil. Alere's Revenue for the three months ended in Jun. 2017 was $557.67 Mil. Therefore, Alere's net margin for the quarter that ended in Jun. 2017 was -16.69%.

The historical rank and industry rank for Alere's Net Margin % or its related term are showing as below:

ALRPRB.PFD' s Net Margin % Range Over the Past 10 Years
Min: -47.2 Med: -3.08 Max: 8.29
Current: -10.71

ALRPRB.PFD's Net Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -11.145 vs ALRPRB.PFD: -10.71

Alere Net Margin % Historical Data

The historical data trend for Alere's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alere Net Margin % Chart

Alere Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Net Margin %

Get a 7-Day Free Trial

-3.28

-2.87

-1.29

8.29

-5.79

Alere Quarterly Data
	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17
Net Margin %	Get a 7-Day Free Trial															-5.40	3.75	-18.91	-10.93	-16.69

Competitive Comparison of Alere's Net Margin %

For the Diagnostics & Research subindustry, Alere's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alere's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Alere's Net Margin % distribution charts can be found below:

* The bar in red indicates where Alere's Net Margin % falls into.

Alere Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Alere's Net Margin for the fiscal year that ended in Dec. 2016 is calculated as

Net Margin	=	Net Income (A: Dec. 2016 )	/	Revenue (A: Dec. 2016 )
	=	-137.619	/	2376.335
	=	-5.79 %

Alere's Net Margin for the quarter that ended in Jun. 2017 is calculated as

Net Margin	=	Net Income (Q: Jun. 2017 )	/	Revenue (Q: Jun. 2017 )
	=	-93.068	/	557.672
	=	-16.69 %

Alere (NYSE:ALRPRB.PFD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Alere Net Margin % Related Terms

Thank you for viewing the detailed overview of Alere's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alere (ALRPRB.PFD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Alere Inc (NYSE:ALRPRB.PFD) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.alere.com

Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.

Executives

John Bridgen	officer: Sr VP, Business Development	51 SAWYER ROAD, C/O INVERNESS MEDICAL INNOVATIONS INC, WALTHAM MA 02453
Geoffrey S Ginsburg	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Renuka Uppaluri	officer: Senior VP, Global R&D	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Mark Gladwell	officer: Senior VP, Global Operations	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Gregg J Powers	director	C/O QUANTUM CORPORATION, 224 AIRPORT PARKWAY SUITE 300, SAN JOSE CA 95110
Jonathan Wygant	officer: VP, Controller, CAO	3750 TORREY VIEW COURT, SAN DIEGO X1 92130
Thomas Mckillop	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Melissa Guerdan	officer: SVP, Global Quality & Reg.	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Daniella Cramp	officer: Global Pres., Cardiometabolic	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Sanjay Malkani	officer: Global Pres., Toxicology	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
James Jr. Roosevelt	director	51 SAWYER ROAD, SUITE 200, HOPKINTON MA 02453
Robert Bernard Hargadon	officer: SVP, Global Human Resources	4327 LAKE WASHINGTON BLVD NE #6208, KIRKLAND WA 98033
John F Levy	director	C/O INNVERNESS MEDICAL INNOVATIONS, INC., 51 SAWYER ROAD, WALTHAM MA 02453
John Quelch	director	C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYER RD, WALTHAM MA 02453
Carol R Goldberg	director	C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYERS RD, WALTHAM MA 02453